Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „does“
Suchtreffer
Begriffe & Kennungen
Opdivo · 4.5 · 162 immunosuppression after starting nivolumab treatment does not appear to preclude the response on nivolumab
Eintrag öffnenOrfadin · 4.5 · Food does not influence the bioavailability of nitisinone oral suspension, but intake together with food decre
Eintrag öffnenPolivy · 4.5 · Bendamustine does not affect acMMAE and unconjugated MMAE plasma AUC.
Eintrag öffnenPotactasol · 4.5 · Topotecan does not inhibit human P450 enzymes (see section 5.2). In a population study using the intravenous r
Eintrag öffnenPregabalin Viatris (previously Pregabalin Mylan) · 4.5 · Co-administration of pregabalin with the oral contraceptives norethisterone and/or ethinyl oestradiol does not
Eintrag öffnenPrezista · 4.5 · Unlike ritonavir, cobicistat does not induce CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19 or UGT1A1. For further in
Eintrag öffnenPrezista · 4.5 · Unlike ritonavir, cobicistat does not induce CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19 or UGT1A1. For further in
Eintrag öffnenPrialt · 4.5 · Ziconotide does not interact with opiate receptors. If discontinuing opiates when initiating ziconotide therap
Eintrag öffnenPrialt · 4.5 · Ziconotide does not interact with opiate receptors. If discontinuing opiates when initiating ziconotide therap
Eintrag öffnenPylclari · 4.5 · Chronic treatment with diuretics does not seem to have any interference with piflufolastat (18F) for interpret
Eintrag öffnenRaloxifene Teva · 4.5 · Co-administration of raloxifene and warfarin does not alter the pharmacokinetics of either compound. However,
Eintrag öffnenRaloxifene Teva · 4.5 · Raloxifene does not affect the steady-state AUC of digoxin. The Cmax of digoxin increased by less than 5 %.
Eintrag öffnenRapiscan · 4.5 · Other interactions Regadenoson does not inhibit the metabolism of substrates for CYP1A2, CYP2C8, CYP2C9, CYP2C
Eintrag öffnenRapiscan · 4.5 · Regadenoson does not significantly inhibit the transporters OAT1, OAT3, OCT1, OATP1B1, OATP1B3, MATE1, MATE2-K
Eintrag öffnenRasilez · 4.5 · CYP450 interactions Aliskiren does not inhibit the CYP450 isoenzymes (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A)
Eintrag öffnenRelistor · 4.5 · Methylnaltrexone bromide does not affect the pharmacokinetics of medicinal products metabolised by cytochrome
Eintrag öffnenRelistor · 4.5 · Methylnaltrexone bromide does not affect the pharmacokinetics of medicinal products metabolised by cytochrome
Eintrag öffnenRelistor · 4.5 · Methylnaltrexone bromide does not affect the pharmacokinetics of medicinal products metabolised by cytochrome
Eintrag öffnenRiltrava Aerosphere · 4.5 · 20 Formoterol does not inhibit the CYP450 enzymes at therapeutically relevant concentrations (see section 5.2)
Eintrag öffnenRiltrava Aerosphere · 4.5 · 5 Formoterol does not inhibit the CYP450 enzymes at therapeutically relevant concentrations (see section 5.2).
Eintrag öffnen